Acute Myeloid Leukaemia
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
June, 2024
June 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
« May
Acute Myeloid Leukaemia
Jun 21, 2024, 13:21 |
Blog
Stellar talks from pioneering generation of haematologists at EHA2024 - Guezguez lab
Guezguez lab shared a post on X: “And it's a wrap for another fantastic European…
May 26, 2024, 02:20 |
Blog
Shahrin Ahmed: New treatment for a form of acute myeloid leukaemia approved for use on NHS - UK
Shahrin Ahmed, Medical Specialist at Canadian Cancer Society, made the following post on X: "Blood…
May 21, 2024, 04:55 |
Drugs
Jayastu Senapati: Optimal use of Azacytidine Venetoclax in AML Patients in Indian Scenario
Jayastu Senapati, Assistant Professor of Leukemia at MD Anderson Cancer Center, shared a post on X:…
May 19, 2024, 09:37 |
Blog
Eline Bertrums on International collaborations and Genetic Insights in Childhood Cancer
Eline Bertrums, Physician assistant (ANIOS) pediatrics at Gelderland Valley Hospital, shared a post on LinkedIn:…
May 14, 2024, 15:10 |
Blog
Naval Daver shares updates on novel emerging therapies in AML - MD Anderson Cancer Center
MD Anderson Cancer Center shared on X: “There’s much more optimism and hope that we…
Sep 27, 2023, 18:06 |
Drugs
Hagop Kantarjian: Combination of venetoclax and hypomethylating agent provides high rates of durable remission and overall survival in both newly diagnosed and R/R IDH1/2-mutated Acute Myeloid Leukemia.
Sep 26, 2023, 18:52 |
Blog
Valeria Santini: Our recent publication on the treatment of very elderly acute myeloid leukemia is finally supporting choice of treatment for these challenging patients.
Valeria Santini, Professor of Hematology at the University of Florence, shared on X/Twitter: “Our recent…
Sep 17, 2023, 16:54 |
Opinion
Andres Gomez: In my view, the most important issue for AML patients worldwide is lack of access to comprehensive testing.
Quoting Andres Gomez, Associate Professor at UANL Monterrey, Mexico, on X/Twitter: "I like the paper…
All:
8
Posts:
1 - 10
New Paper Alert! Long-Term Benefits of Dabrafenib-Trametinib in Stage III Melanoma: 8-Year COMBI-AD Trial Results
We mourn the loss of our Ivy Elkins
FDA grants accelerated approval to adagrasib with cetuximab for KRAS G12C-mutated colorectal cancer
Rob Winn: Honored to receive the ASCO Allen Lichter Visionary Leader Award
Yardena Samuels: An absolute honor to be elected as the next EACR president
Facebook
RSS Feed
Twitter
Linkedin
Youtube